Molecular recognition of insulin by a synthetic receptor. 2011

Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
Department of Chemistry, Trinity University, One Trinity Place, San Antonio, Texas 78212, USA.

The discovery of molecules that bind tightly and selectively to desired proteins continues to drive innovation at the interface of chemistry and biology. This paper describes the binding of human insulin by the synthetic receptor cucurbit[7]uril (Q7) in vitro. Isothermal titration calorimetry and fluorescence spectroscopy experiments show that Q7 binds to insulin with an equilibrium association constant of 1.5 × 10(6) M(-1) and with 50-100-fold selectivity versus proteins that are much larger but lack an N-terminal aromatic residue, and with >1000-fold selectivity versus an insulin variant lacking the N-terminal phenylalanine (Phe) residue. The crystal structure of the Q7·insulin complex shows that binding occurs at the N-terminal Phe residue and that the N-terminus unfolds to enable binding. These findings suggest that site-selective recognition is based on the properties inherent to a protein terminus, including the unique chemical epitope presented by the terminal residue and the greater freedom of the terminus to unfold, like the end of a ball of string, to accommodate binding. Insulin recognition was predicted accurately from studies on short peptides and exemplifies an approach to protein recognition by targeting the terminus.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D001952 Bridged-Ring Compounds Cyclic hydrocarbons that contain multiple rings which share one or more bridgehead connections. Bridged Compounds,Bridged Ring Compounds
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
May 1988, Immunological investigations,
Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
February 2004, Immunology letters,
Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
January 2014, Advances in science and technology (Owerri, Nigeria),
Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
December 1997, Current opinion in chemical biology,
Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
April 2024, Chemical science,
Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
January 2014, Beilstein journal of organic chemistry,
Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
November 2011, Organic & biomolecular chemistry,
Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
December 1990, Science (New York, N.Y.),
Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
November 2018, Chemical communications (Cambridge, England),
Jordan M Chinai, and Alexander B Taylor, and Lisa M Ryno, and Nicholas D Hargreaves, and Christopher A Morris, and P John Hart, and Adam R Urbach
December 1999, Journal of medicinal chemistry,
Copied contents to your clipboard!